Defective expression of prohormone convertase 4 and enhanced expression of insulin-like growth factor II by pleural solitary fibrous tumor causing hypoglycemia

Endocrine Journal

Volumn 55, Issue 5, 2008, Pages 905-911

  Tani, Yuji ^a   Tateno, Toru ^a   Izumiyama, Hajime ^a   Doi, Masaru ^a   Yoshimoto, Takanobu ^a   Hirata, Yukio ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Insulin like growth factor II; Non islet cell tumor hypoglycemia; Prohormone convertase 4

Indexed keywords

DEXAMETHASONE; FURIN; GLUCOSE; INSULIN; PROHORMONE CONVERTASE 4; SOMATOMEDIN B; SOMATOMEDIN C; UNCLASSIFIED DRUG;

AGED; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; FATIGUE; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOGLYCEMIA; IMMUNOHISTOCHEMISTRY; INSULIN BLOOD LEVEL; MALE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOLITARY FIBROUS TUMOR; SWEATING; THORAX RADIOGRAPHY; UNCONSCIOUSNESS; WESTERN BLOTTING;

AGED; BLOTTING, WESTERN; GENE EXPRESSION; HUMANS; HYPOGLYCEMIA; IMMUNOHISTOCHEMISTRY; INSULIN; INSULIN-LIKE GROWTH FACTOR II; MALE; MOLECULAR WEIGHT; PROPROTEIN CONVERTASES; PROTEIN PRECURSORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SOLITARY FIBROUS TUMOR, PLEURAL; SUBTILISINS;

EID: 55049093606     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K08E-062     Document Type: Article

References (15)

1. Hizuka N, Fukuda I, Takano K, Okubo Y, Asakawa-Yasumoto K, Demura H (1998) Serum insulin-like growth factor II in 44 patients with non-islet cell tumor hypoglycemia. Endocr J 45 Suppl: S61-S65.
2. de Groot JW, Rikhof B, van Doorn J, Bilo HJ, Alleman MA, Honkoop AH, van der Graaf WT (2007) Non-islet cell tumour-induced hypoglycaemia: a review of the literature including two new cases. Endocr Relat Cancer 14: 979-993.
3. Duguay SJ, Jin Y, Stein J, Duguay AN, Gardner P, Steiner DF (1998) Post-translational processing of the insulin-like growth factor-2 precursor. Analysis of O-glycosylation and endoproteolysis. J Biol Chem 273: 18443-18451.
4. Qiu Q, Basak A, Mbikay M, Tsang BK, Gruslin A (2005) Role of pro-IGF-II processing by proprotein convertase 4 in human placental development. Proc Natl Acad Sci USA 102: 11047-11052.
5. Tateno T, Nakamura N, Hirata Y, Hirose S (2006) Role of C-terminus of Kir7.1 potassium channel in cell-surface expression. Cell Biol Int 30: 270-277.
6. Sato R, Tsujino M, Nishida K, Otani Y, Minami T, Shichiri M, Hizuka N, Aiba M, Hitara Y (2004) High molecular weight form insulin-like growth factor II-producing mesenteric sarcoma causing hypoglycemia. Intern Med 43: 967-971.
7. Daughaday WH, Kapadia M (1989) Significance of abnormal serum binding of insulin-like growth factor II in the development of hypoglycemia in patients with non-islet-cell tumors. Proc Natl Acad Sci USA 86: 6778-6782.
8. Elmlinger MW, Rauschnabel U, Koscielniak E, Weber K, Ranke MB (1999) Secretion of noncomplexed 'Big' (10-18 kD) forms of insulin-like growth factor-II by 12 soft tissue sarcoma cell lines. Horm Res 52: 178-185.
9. Zapf J, Futo E, Peter M, Froesch ER (1992) Can "big" insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia? J Clin Invest 90: 2574-2584.
10. Bond JJ, Meka S, Baxter RC (2000) Binding characteristics of pro-insulin-like growth factor-II from cancer patients: binary and ternary complex formation with IGF binding proteins-1 to -6. J Endocrinol 165: 253-260.
11. Frystyk J, Skjaerbaek C, Zapf J, Orskov H (1998) Increased levels of circulating free insulin-like growth factors in patients with non-islet cell tumour hypoglycaemia. Diabetologia 41: 589-594.
12. Basak A, Toure BB, Lazure C, Mbikay M, Chretien M, Seidah NG (1999) Enzymic characterization in vitro of recombinant proprotein convertase PC4. Biochem J 343 Pt 1: 29-37.
13. Daughaday WH, Trivedi B, Baxter RC (1993) Serum "big insulin-like growth factor II" from patients with tumor hypoglycemia lacks normal E-domain O-linked glycosylation, a possible determinant of normal propeptide processing. Proc Natl Acad Sci USA 90: 5823-5827.
14. Hizuka N, Fukuda I, Takano K, Asakawa-Yasumoto K, Okubo Y, Demura H (1998) Serum high molecular weight form of insulin-like growth factor II from patients with non-islet cell tumor hypoglycemia is O-glycosylated. J Clin Endocrinol Metab 83: 2875-2877.
15. Herman V, Kalk WJ, de Moor NG, Levin J (1981) Serum prolactin after chest wall surgery: elevated levels after mastectomy. J Clin Endocrinol Metab 52: 148-151.